Anyone investing heavily this year??
- Thread starter rph2005
- Start date
I'm up in $DIS, but I am cutting them for now.
Before the pandemic's onset, The Walt Disney Company (NYSE
IS) paid a semi-annual dividend. However, when it was forced to shut its doors to several of its most lucrative businesses worldwide, Disney felt it prudent to pause the dividend payment to conserve cash.
www.fool.com
Before the pandemic's onset, The Walt Disney Company (NYSE
IS) paid a semi-annual dividend. However, when it was forced to shut its doors to several of its most lucrative businesses worldwide, Disney felt it prudent to pause the dividend payment to conserve cash.
Disney's CEO Says No Dividend Anytime Soon | The Motley Fool
Disney CEO Bob Chapek made comments regarding the company's dividends at an investor conference.
www.fool.com
Man damn thanks for that. Up like 35% on my little investment lol
You gave that man golden tip right there
... They trailing stop saves you from so many frustrating moments
As soon as i get that break out im dumping this shit!! No more nio for me... i need some more dividends...
Me too as soon as I break even i am dumping this shit. I might buy a leap or two later on if the premium is cheap but I am trying to stay away from these Chinese stocks
Which dividend stocks you like?
Quick update: CEI 32% gain.
Back to watching naked women I go
Man this shit is wild Bro...Tempted to buy some more lol
wait what? explain
One of those old dinosaurs that always gets it wrong
So pretty much the opposite of what he says is happening will happen
Nice simplification. Got anything like this for Crypto, I try to explain what I know, but wind-up getting real LONG-WINDED and they glaze over on me.
Taiwan Semiconductor Posts Higher Q3 Earnings, Revenue; Issues Q4 Revenue Guidance
MT NEWSWIRES - 3:58 AM ET
03:58 AM EDT, 10/14/2021 (MT Newswires) -- Taiwan Semiconductor (TSM) reported Q3 earnings Thursday of 30.13 New Taiwan dollars ($1.08) per American depositary receipt, up from NT$26.48 per ADR a year earlier.
Net revenue rose to NT$414.67 billion for the quarter ended Sept. 30 from NT$356.43 billion a year ago. Analysts polled by Capital IQ projected revenue of NT$413.47 billion.
Price: 109.98, Change: +0.78, Percent Change: +0.71
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
© 1999-2021 Midnight Trader, Inc. All rights reserved.
MT NEWSWIRES - 3:58 AM ET
03:58 AM EDT, 10/14/2021 (MT Newswires) -- Taiwan Semiconductor (TSM) reported Q3 earnings Thursday of 30.13 New Taiwan dollars ($1.08) per American depositary receipt, up from NT$26.48 per ADR a year earlier.
Net revenue rose to NT$414.67 billion for the quarter ended Sept. 30 from NT$356.43 billion a year ago. Analysts polled by Capital IQ projected revenue of NT$413.47 billion.
Price: 109.98, Change: +0.78, Percent Change: +0.71
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
© 1999-2021 Midnight Trader, Inc. All rights reserved.
$UNH
UnitedHealth Shares Climb on Earnings Beat, Raised Guidance for 2022 -- Barrons.com
BY JOSH NATHAN-KAZIS | DOW JONES & COMPANY, INC. - 6 MINUTES AGO
Shares of the major health insurer UnitedHealth Group (UNH) leapt 5.3% Thursday morning after the company reported financial results that blew past Wall Street expectations.
UnitedHealth (UNH) reported adjusted earnings of $4.52 a share, 2.5% better than the FactSet consensus estimate of $4.41 a share. The company reported revenue of $72.3 billion, 11% better than the same quarter last year, and above the $71.3 billion FactSet consensus estimate.
The company also raised its guidance for the full 2022 fiscal year, saying it now expects adjusted earnings of between $18.65 and $18.90 a share, up from its earlier guidance of between $18.30 and $18.80 a share. The new guidance is roughly in line with the FactSet consensus estimate of $18.75 a share.
What's more, UnitedHealth (UNH) said that its medical care ratio, also known as the medical loss ratio, which measures the percentage of premiums paid out to cover costs, was slightly lower than the FactSet consensus estimate of 83.5%, at 83%.
"The results reinforce our view that despite some near-term uncertainty around medical costs, we believe fundamentals at UNH are strong and we expect another solid year in 2022," Cantor Fitzgerald analyst Steven Halper wrote in a note out early Thursday.
Analysts said that the results resolved near-term overhangs, and shifted the focus to next year. "With these very good results, we can shift to "what have you done for us lately" and focus on the 2022 outlook," wrote BMO Equity Research analyst Matt Borsch in Thursday note.
Borsch noted that the financial results did not show evidence of a post-pandemic rebound in healthcare utilization.
"It's been interesting over the course of the 20 months, there has been a consistent, fairly rapid reaction when COVID cases go up nationally in terms of the preference of patients whether or not to seek elective care, " said UnitedHealth's (UNH) Chief Financial Officer John Rex on an investor call early Thursday. "That again happened this quarter."
UnitedHealth (UNH) shares are up 21.5% this year, a period in which the S&P 500 Health Care Sector Index is up 10.5%. The broader S&P 500 is up 17.8%. Of the 28 analysts tracked by FactSet who cover the stock, 24 rate it Buy or Overweight, while three rate it a Hold, and one rates it Underweight.
Write to Josh Nathan-Kazis a josh.nathan-kazis@barrons.com
(END) Dow Jones Newswires
10-14-21 1135ET
Copyright (c) 2021 Dow Jones & Company, Inc.
UnitedHealth Shares Climb on Earnings Beat, Raised Guidance for 2022 -- Barrons.com
BY JOSH NATHAN-KAZIS | DOW JONES & COMPANY, INC. - 6 MINUTES AGO
Shares of the major health insurer UnitedHealth Group (UNH) leapt 5.3% Thursday morning after the company reported financial results that blew past Wall Street expectations.
UnitedHealth (UNH) reported adjusted earnings of $4.52 a share, 2.5% better than the FactSet consensus estimate of $4.41 a share. The company reported revenue of $72.3 billion, 11% better than the same quarter last year, and above the $71.3 billion FactSet consensus estimate.
The company also raised its guidance for the full 2022 fiscal year, saying it now expects adjusted earnings of between $18.65 and $18.90 a share, up from its earlier guidance of between $18.30 and $18.80 a share. The new guidance is roughly in line with the FactSet consensus estimate of $18.75 a share.
What's more, UnitedHealth (UNH) said that its medical care ratio, also known as the medical loss ratio, which measures the percentage of premiums paid out to cover costs, was slightly lower than the FactSet consensus estimate of 83.5%, at 83%.
"The results reinforce our view that despite some near-term uncertainty around medical costs, we believe fundamentals at UNH are strong and we expect another solid year in 2022," Cantor Fitzgerald analyst Steven Halper wrote in a note out early Thursday.
Analysts said that the results resolved near-term overhangs, and shifted the focus to next year. "With these very good results, we can shift to "what have you done for us lately" and focus on the 2022 outlook," wrote BMO Equity Research analyst Matt Borsch in Thursday note.
Borsch noted that the financial results did not show evidence of a post-pandemic rebound in healthcare utilization.
"It's been interesting over the course of the 20 months, there has been a consistent, fairly rapid reaction when COVID cases go up nationally in terms of the preference of patients whether or not to seek elective care, " said UnitedHealth's (UNH) Chief Financial Officer John Rex on an investor call early Thursday. "That again happened this quarter."
UnitedHealth (UNH) shares are up 21.5% this year, a period in which the S&P 500 Health Care Sector Index is up 10.5%. The broader S&P 500 is up 17.8%. Of the 28 analysts tracked by FactSet who cover the stock, 24 rate it Buy or Overweight, while three rate it a Hold, and one rates it Underweight.
Write to Josh Nathan-Kazis a josh.nathan-kazis@barrons.com
(END) Dow Jones Newswires
10-14-21 1135ET
Copyright (c) 2021 Dow Jones & Company, Inc.